(IPCI) 6 Drugs awaiting FDA Approval (Mcap 47 M) !!!

[Biotechmaster]

A NEW TEVA IS IN THE MAKING HERE FOLKS....PATIENCE IS ALL YOU NEED TO GET RICH WITH THIS ONE !!!! GLTA

This low float sleeping giant awaiting 6 FDA approvals .IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including a potential Blockbuster .

Burn-rate is only 1.5 M per Q means enuff till 2013 EXCLUDING upfront payments from Upcoming Partnerships . IPCI will be profitable in 2012 !!!

CEO is the largest Shareholder of this unknown Goldmine with over 6 M shares .First FDA approval and new Partnership is imminent ..


Intellipharmaceutics (IPCI)

Market Cap: $ 47.7 M
Cash: $ 7.5 M
Price: $3

Shares Out: 15.9 Mil...(11 Mil Shares held by Insiders/Institutions)
Low Float: Only 3 M


MONSTER Pipeline



New Article ( worth $15++ per share )



Upcoming Milestones 2011




Intellipharmaceutics now has six ANDAs being reviewed by the FDA for approval, with reported sales by others for branded and generic versions of these products being approximately $6.6 billion for the 12 months ended September 2011. The Company develops both ANDA product candidates and new drugs through the New Drug Application (NDA) 505(b)(2) regulatory pathway.
..

Ladenburg Thalmann has initiated coverage of Intellipharmaceutics International (NADAQ:IPCI; TSX:I) with a